The Current Ratio as of November 2024 (TTM) for Ensysce Biosciences, Inc. (ENSC) is 3.24

According to Ensysce Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.24. This represents a change of 49.44% compared to the average of 2.17 of the last 4 quarters.

Ensysce Biosciences, Inc. (ENSC) Historical Current Ratio (quarterly & annually)

How has ENSC Current Ratio performed in the past?

The mean historical Current Ratio of Ensysce Biosciences, Inc. over the last ten years is 3.12. The current 3.24 Current Ratio has changed 10.31% with respect to the historical average. Over the past ten years (40 quarters), ENSC's Current Ratio was at its highest in in the March 2018 quarter at 10.77. The Current Ratio was at its lowest in in the December 2017 quarter at 0.

Ensysce Biosciences, Inc. (ENSC) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Ensysce Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ensysce Biosciences, Inc. (ENSC) Average Current Ratio

How has ENSC Current Ratio performed in the past?

The current Current Ratio of Ensysce Biosciences, Inc. (ENSC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Ensysce Biosciences, Inc. (ENSC) Current Ratio vs. Peers

How is ENSC’s Current Ratio compared to its peers?

Ensysce Biosciences, Inc.’s Current Ratio is less than Zura Bio Limited (10.36), less than Phio Pharmaceuticals Corp. (6.38), greater than Sonnet BioTherapeutics Holdings, Inc. (1.65), greater than 180 Life Sciences Corp. (0.19), less than Cardio Diagnostics Holdings, Inc. (8.51), less than Virax Biolabs Group Limited (25.94), greater than Blue Water Vaccines, Inc. (0.54), greater than Revelation Biosciences, Inc. (1.64), greater than Hillstream BioPharma, Inc. (2.25), less than Kiora Pharmaceuticals, Inc. (8.97), greater than Quoin Pharmaceuticals, Ltd. (3.02), greater than Allarity Therapeutics, Inc. (2.75), greater than Kiromic BioPharma, Inc. (0.22), greater than Biodexa Pharmaceuticals Plc (2.16), greater than PaxMedica, Inc. Common Stock (0.38),

Build a custom stock screener for Ensysce Biosciences, Inc. (ENSC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ensysce Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ensysce Biosciences, Inc. (ENSC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ensysce Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.